Dermaliq Therapeutics, Inc.

📍 Wilmington, United States🗓 Founded 2021👥 5 employees💰 Last funded Mar 2022
Pharmaceutical Manufacturing🌐 dermaliq.com
Website LinkedIn
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The unique and proprietary technology owned by Dermaliq, called hyliQTM, is designed to allow cutaneous drug delivery with unmatched bioavailability. The technology enables the development of superior, highly effective liquid drug products with exceptional cosmetic properties.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Dermaliq Therapeutics, Inc.?
Dermaliq Therapeutics, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Dermaliq Therapeutics, Inc. last raise funding?
The most recent investment in Dermaliq Therapeutics, Inc. recorded on gritt.io was in March 2022.
When was Dermaliq Therapeutics, Inc. founded?
Dermaliq Therapeutics, Inc. was founded in 2021.
What industry is Dermaliq Therapeutics, Inc. in?
Dermaliq Therapeutics, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Dermaliq Therapeutics, Inc. based?
Dermaliq Therapeutics, Inc. is headquartered in Wilmington, United States.